Tag: Agile Therapeutics Inc

  • Drug Stocks: Fibrocell Science Inc (NYSEMKT:FCSC), Versartis Inc (NASDAQ:VSAR), Agile Therapeutics Inc (NASDAQ:AGRX), Walgreen Company (NYSE:WAG), China Jo Jo Drugstores Inc (NASDAQ:CJJD)

    Fibrocell Science, Inc. (NYSEMKT:FCSC) was a big mover last session, as the company saw its shares rise by almost 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained over 29% since May 21, according to Zack. Fibrocell Science Inc (NYSEMKT:FCSC) weekly performance is 18.31%. On last trading day company shares ended up $3.49. Analysts mean target price for the company is $8.13. Fibrocell Science Inc (NYSEMKT:FCSC) distance from 50-day simple moving average (SMA50) is -6.14%.

    Versartis, Inc. (NASDAQ:VSAR) an endocrine-focused biopharmaceutical company that is developing a novel, long-acting form of recombinant human growth hormone (rhGH) for the treatment of growth hormone deficiency (GHD), announced it will hold a conference call and webcast on Monday, June 23, 2014 at 5:00 p.m. EDT (4:00 p.m. CDT). Versartis Inc (NASDAQ:VSAR) shares advanced 3.69% in last trading session and ended the day on $33.44. Its return on assets is -515.40%.

    On May 29, 2014, Agile Therapeutics, Inc. (NASDAQ:AGRX)filed an amended and restated certificate of incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware in connection with the closing of the Company’s initial public offering of shares of its common stock. The Company’s board of directors (the “Board”) and stockholders previously approved the Restated Certificate effective as of and contingent upon the closing of the Company’s initial public offering. Agile Therapeutics Inc (NASDAQ:AGRX) shares moved up 4.83% in last trading session and was closed at $6.30, while trading in range of $5.77 – $6.35. Agile Therapeutics Inc (NASDAQ:AGRX) year to date (YTD) performance is 13.72%.

    Walgreen Company (NYSE:WAG) had its price target increased by Mizuho from $78.00 to $83.00 in a research report sent to investors on Monday morning. The firm currently has a buy rating on the stock. Walgreen Company (NYSE:WAG) ended the last trading day at $74.74. Company weekly volatility is calculated as 2.45% and price to cash ratio as 40.14. Walgreen Company (NYSE:WAG) showed a positive weekly performance of 4.44%.

    China Jo Jo Drugstores Inc (NASDAQ:CJJD) net profit margin is -30.90% and weekly performance is 2.41%. On last trading day company shares ended up $1.70. Analysts mean target price for the company is $7.00. China Jo Jo Drugstores Inc (NASDAQ:CJJD) distance from 50-day simple moving average (SMA50) is -13.01%.